풍선 대동맥 판막성형술 시장 규모는 2023년 1억 2,508만 달러에서 2031년까지 1억 9,027만 달러에 이를 것으로 예상됩니다. 시장은 2023~2031년 동안 연평균 성장률(CAGR) 5.4%를 기록할 것으로 예상됩니다. 경피적 대동맥 판막 이식(TAVI)을 개선하는 데 도움이 되는 새로운 연구 및 개발 전략은 시장의 주요 트렌드로 남을 가능성이 높습니다.
풍선 대동맥 판막성형술 시장 분석
풍선 판막 성형술 장치 시장의 성장을 이끄는 요인에는 급격한 인구 노령화와 대동맥 판막 협착증의 유병률 증가가 포함됩니다. 대동맥 협착증은 수술적 치료가 필요한 가장 흔한 판막 질환이 되었습니다. 풍선 대동맥 판막성형술(BAV)은 TAVI 시술에서의 역할 외에도 판막 교체에 대한 연결 요법일 뿐만 아니라 대동맥 협착증이 있는 광범위한 환자에게 도움이 될 수 있습니다. 풍선 판막 성형술 장치에 대한 의료 상환 가능성의 증가, 최소 침습 수술의 채택 증가, 더 나은 의료 인프라도 시장 성장에 기여하는 추가 요인입니다. 최소 침습 접근법은 일반적으로 심장에 접근하기 위해 특수 기구와 기술을 사용하여 더 작은 절개를 포함하므로 입원 기간이 단축되고 흉터가 덜 발생할 수 있습니다. 또한 의료 기관은 최소 침습 BAV 및 TAVI 수술에 대한 증가하는 수요를 충족하기 위해 의료 팀을 교육하고 필요한 장비를 확보하는 데 투자하여 환자에게 향상된 치료 옵션과 더 나은 전반적인 의료 경험을 제공하고 있습니다. 따라서 풍선 대동맥 판막 성형술 시장은 눈에 띄는 성장을 목격하고 있습니다.
풍선 대동맥 판막성형술 시장 개요
심각한 심장 판막 질환을 앓고 있는 환자의 절반 이상이 증상이 나타난 지 2년 이내에 사망합니다. Global Heart Hub가 Heart Valve Voice Canada 2020에 발표한 설문 조사 결과에 따르면 60세 이상의 캐나다인 중 3%만이 대동맥 협착증을 알고 있는 것으로 나타났습니다. 따라서 심장 판막 질환에 대한 인식을 높이고 조기 발견하는 것은 환자는 물론 환자에게 의존하는 사람들과 지역 사회에 필수적입니다. 캐나다 심장혈관학회는 캐나다 내 심장 판막 질환 치료의 격차를 해결하기 위해 심장 판막 질환 전략 실무 그룹을 구성했습니다. 2021년 1월, 메드트로닉은 캐나다 보건부로부터 Evolut TAVI 시스템에 대한 확장 적응증을 받았습니다. 메드트로닉의 TAVI 플랫폼은 두 이첨 대동맥 판막(중등도 또는 고위험 환자) 모두에 대해 라이센스를 받은 유일한 시스템입니다. 에볼루트는 모든 위험 범주에 걸쳐 중증 대동맥 협착증 환자에게 국내에서 사용 허가를 받았다. 2021년 9월, Abbott는 개심 수술 위험이 높은 증상이 있는 중증 대동맥 협착증 환자를 치료하기 위한 FlexNav 경피적 대동맥 판막 교체(TAVR) 시스템을 갖춘 Portico에 대해 미국 식품의약국(FDA) 승인을 받았습니다.
귀하의 요구 사항에 맞게 연구를 맞춤화하십시오
우리는 표준 제품을 통해 충족되지 않는 분석과 범위를 최적화하고 조정할 수 있습니다. 이러한 유연성은 비즈니스 계획 및 의사 결정에 필요한 정확한 정보를 얻는 데 도움이 됩니다.
풍선 대동맥 판막성형술 시장:
CAGR(2023~2031)5.4%- 시장 규모 2023
US$�125.08 Million - 시장규모 2031년
US$�190.27 Million
시장 역학
- 대동맥 판막 협착증의 유병률 증가
- 최소 침습적 시술에 대한 수요 증가
- 대동맥 판막 교체 기술의 발전
주요 선수
- B 브라운 SE
- 티티메디컬(주)
- 발턴
- Becton Dickinson 및 공동
- 에드워드 생명과학 주식회사
- 발트
- Venus MedTech HangZhou Inc.
- 누메드
- 시멕스
- OSYPKA
지역 개요
- 북아메리카
- 유럽
- 아시아 태평양
- 남미 및 중미
- 중동 및 아프리카
시장 세분화
상품 유형- 비준수 풍선
- 준규격 풍선
- 샘플 PDF는 정성적, 정량적 분석을 통해 콘텐츠 구조와 정보의 성격을 보여줍니다.
풍선 대동맥 판막 성형술 시장 동인 및 기회
최소 침습적 시술에 대한 수요 증가로 시장 성장 촉진
The soaring demand for minimally invasive techniques in valve replacement surgeries reflects a significant shift in medical practices and patient preferences. In a minimally invasive aortic valvuloplasty, the heart's aortic valve is repaired and, if needed, replaced through TAVI procedures. Minimally invasive techniques are driven by the desire to reduce the invasiveness of procedures, minimize the associated risks, and promote faster recovery times.
All branches of medicine, including cardiology, are witnessing an increase in the demand for less invasive procedures because of several benefits over traditional open-heart surgery. Compared to open-heart surgery, patients who undergo minimally invasive procedures usually have a shorter recovery time. In addition, minimally invasive techniques have a lower risk of complications and result in fewer scars compared to open cardiac surgery. Surgeons have adopted these techniques due to advancements in medical devices, and improved surgical skills can further facilitate widespread adoption. As BAV is a minimally invasive technique that can be used to treat a variety of heart problems, including aortic valve stenosis, the market for BAV devices is driven by the increased demand for minimally invasive procedures.
Advancements in Aortic Valve Replacement Technologies
Patients with heart conditions experience improved symptoms within a shorter period when treated with transcatheter procedures compared with surgical interventions. Minimally invasive surgical techniques, such as TAVI, have modernized the treatment of aortic stenosis due to advancements. Additionally, improvements in design have led to the development of stronger and biocompatible aortic valve replacements, which have enhanced patient outcomes and lowered the risk of complications. A few technological advancements by the companies in balloon aortic valvuloplasty and aortic valve replacement devices are mentioned below:
- In January 2023, Abbott received FDA approval for the Navitor TAVI system to treat patients with severe aortic stenosis and those who are ineligible for open-heart surgery. Navitor has been newly introduced in the company's extensive transcatheter structural heart portfolio; it offers physicians and patients less invasive treatment alternatives for a range of serious heart conditions.
- In September 2020, Boston Scientific introduced the ACURATE neo2 aortic valve system in Europe. The next-generation TAVI technology—a new platform designed with multiple features to improve the clinical performance of the original ACURATE neo platform—had an extended indication for patients with aortic stenosis compared to the aortic valve system of the previous generation.
Therefore, technological advancements are offering lucrative opportunities for the balloon aortic valvuloplasty market growth.
Balloon Aortic Valvuloplasty Market Report Segmentation Analysis
The key segment that contributed to the derivation of the balloon aortic valvuloplasty market analysis is product type.
Based on product type, the balloon aortic valvuloplasty market is bifurcated into non-compliant balloons and semi-compliant balloons. The non-compliant balloons segment held a larger market share in 2023 and is expected to register a higher CAGR in the market during 2023–2031.
Balloon Aortic Valvuloplasty Market Share Analysis by Geography
The geographic scope of the balloon aortic valvuloplasty market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America held a significant share of the market. The growth of the market in this region is attributed to the rising prevalence of heart valve diseases, increasing initiatives by various organizations to raise awareness about heart valve diseases among the population, and advancements made in treatment devices. According to the Organization for Economic Co-operation and Development, the burden of cardiovascular diseases is increasing rapidly in Mexico. The risk factors associated with heart diseases among the adult and geriatric population are being addressed in Mexico via awareness programs. In response to these awareness programs, transcatheter aortic valve replacement surgeries have gained traction and are commonly preferred as an alternative to open-heart valve surgery. Cardiologists in Mexico City perform TAVI using the best technology and techniques. CMQ Hospitals is a leader in the TAVI procedure in Puerto Vallarta and Riviera Nayarit. The hospitals have a multidisciplinary team of professionals in interventional cardiology, guaranteeing comprehensive and personalized care for each patient.
The most common cause of aortic stenosis in Canada is degenerative valve disease due to aging, followed by congenital bicuspid aortic valve disease and rheumatic heart disease. As per the “Heart Valve Disease in Canada,” published by the Institute of Health Economics in March 2022, aortic stenosis and mitral regurgitation are the two most common heart valve diseases. About 2.5% of the country’s population is reported to have heart valve disease, which increases significantly after the age of 65, reaching 13% in people aged 75 and above. It is estimated that 1.5 million people aged above 65 will suffer from heart valve disease by 2040 in Canada.
In Canada, a significant number of market players offer TAVI products. Edwards Lifesciences, Boston Scientific Corporation, Medtronic Inc., JenaValve Technology, and Transcatheter Technologies GmbH are a few manufacturers operating in the market. These manufacturers have received regulatory approvals from the Canadian government. Edwards SAPIEN and Medtronic CoreValve systems have been granted licenses in Canada.
Balloon Aortic Valvuloplasty Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$�125.08 Million |
| Market Size by 2031 | US$�190.27 Million |
| 글로벌 CAGR(2023~2031) | 5.4% |
| 과거 데이터 | 2021-2022 |
| 예측기간 | 2024년부터 2031년까지 |
| 해당 세그먼트 | 제품 유형별
|
| 해당 지역 및 국가 | 북아메리카
|
| 시장 리더 및 주요 회사 프로필 |
|
- 샘플 PDF는 정성적, 정량적 분석을 통해 콘텐츠 구조와 정보의 성격을 보여줍니다.
풍선 대동맥 판막 성형술 시장 뉴스 및 최근 개발
풍선 대동맥 판막성형술 시장은 중요한 기업 간행물, 협회 데이터 및 데이터베이스를 포함하는 1차 및 2차 연구 후 정성적 및 정량적 데이터를 수집하여 평가됩니다. 풍선 대동맥 판막성형술 시장의 몇 가지 발전 사항은 다음과 같습니다.
- Abbott는 인도에서 최신 세대 TAVI 시스템인 Navitor를 출시하여 인도에서 수술 위험이 높거나 극단적인 중증 대동맥 협착증 환자가 사용할 수 있는 최소 침습 장치를 만들었습니다. Navitor는 심장 주기와 함께 작용하여 판막 주위 누출로 알려진 판막 프레임 전체의 혈액 역류를 최소화하거나 제거하는 고유한 직물 커프(NaviSeal)를 특징으로 합니다. (출처: Abbott, 보도 자료, 2022년 12월)
- Keystone Heart, Ltd.는 풍선 대동맥 판막성형술 제품 포트폴리오를 미국에서 판매 및 판매하기 위해 InterValve Medical Inc.와 독점 유통 계약을 체결했습니다. 이번 계약에 따라 Keystone Heart Ltd.는 미국 시장에서 V8 및 TAV8 대동맥 판막성형술 풍선 카테터(InterValve Medical) 판매를 시작했습니다. (출처: Keystone Heart, Ltd; 보도 자료, 2021년 3월)
풍선 대동맥 판막 성형술 시장 보고서 범위 및 결과물
“풍선 대동맥 판막성형술 시장 규모 및 예측(2021~2031)” 보고서는 아래 영역을 다루는 시장에 대한 자세한 분석을 제공합니다.
- 범위에 포함되는 모든 주요 시장 부문에 대한 글로벌, 지역 및 국가 수준의 풍선 대동맥 판막성형술 시장 규모 및 예측
- 풍선 대동맥 판막 성형술 시장 동향과 동인, 제한 사항 및 주요 기회와 같은 시장 역학
- 상세한 PEST 및 SWOT 분석
- 주요 시장 동향, 글로벌 및 지역 프레임워크, 주요 업체, 규정 및 최근 시장 개발을 다루는 풍선 대동맥 판막 성형술 시장 분석
- 풍선 대동맥 판막 성형술 시장에 대한 시장 집중도, 히트 맵 분석, 주요 플레이어 및 최근 개발을 다루는 산업 환경 및 경쟁 분석
- 자세한 회사 프로필
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The estimated value of the balloon aortic valvuloplasty market can reach US$ 190.27 million by 2031.
North America region dominated the balloon aortic valvuloplasty market in 2023.
B Braun SE, TT Medical, Inc., Balton, Becton Dickinson and Co, Edwards Lifesciences Corp, Balt, Venus MedTech HangZhou Inc., NuMED, simeks, and OSYPKA are among the key market players in the balloon aortic valvuloplasty market.
The global balloon aortic valvuloplasty market is estimated to register a CAGR of 5.4% during the forecast period 2023–2031.
The rising prevalence of aortic valve stenosis and increasing demand for minimally invasive procedures are the most influential factors responsible for market growth.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Balloon Aortic Valvuloplasty Market
- B Braun SE
- TT Medical, Inc.
- Balton
- Becton Dickinson and Co
- Edwards Lifesciences Corp
- Balt
- Venus MedTech HangZhou Inc
- NuMED
- simeks
- OSYPKA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For